18 September 2018
Dr Mark Cowley was awarded grant in collaboration with the Children’s Cancer Institute to enrol neuroblastoma patients onto a targeted clinical trial and investigate how their tumour genomes respond to treatment.
Dr Cowley is also part of a collaboration that was awarded a MRFF Low Survival Cancers and Diseases Project Grant to for the HR-NBL2/SIOPEN high-risk neuroblastoma clinical trial in Australia. This is a randomised clinical trial combined with translational research to improve relapse prediction for high-risk neuroblastoma.
Dr Amali Mallawaarachchi and Dr Cowley, along with researchers and clinicians at the Garvan Institute and St Vincent’s Hospital, were awarded a PKD Foundation Project Grant for their work in understanding the role of genetic variation over someone’s lifetime and new mutational mechanisms in the development of polycystic kidney disease.